pubmed.ncbi.nlm.nih.gov
Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics - PubMed
Pharmacologic complement inhibition offers a promising therapeutic strategy for several complement-mediated kidney diseases. Yet, at present, nephrologists must rely on an incomplete toolkit of histopathologic and circulating biomarkers to assess complement activity in complement-mediated kidney dis …